These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
791 related articles for article (PubMed ID: 25759183)
1. HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple Daily Injections. Heinemann L; Deiss D; Hermanns N; Graham C; Kaltheuner M; Liebl A; Price D J Diabetes Sci Technol; 2015 May; 9(3):651-62. PubMed ID: 25759183 [TBL] [Abstract][Full Text] [Related]
3. Optimization of insulin regimen and glucose outcomes with short-term real-time continuous glucose monitoring (RT-CGM) in type 1 diabetic children with sub-optimal glucose control on multiple daily injections: The pediatric DIACCOR study. Picard S; Bonnemaison-Gilbert E; Leutenegger E; Barat P Arch Pediatr; 2019 Feb; 26(2):95-101. PubMed ID: 30642746 [TBL] [Abstract][Full Text] [Related]
4. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial. Heinemann L; Freckmann G; Ehrmann D; Faber-Heinemann G; Guerra S; Waldenmaier D; Hermanns N Lancet; 2018 Apr; 391(10128):1367-1377. PubMed ID: 29459019 [TBL] [Abstract][Full Text] [Related]
5. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials. Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691 [TBL] [Abstract][Full Text] [Related]
6. Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose Monitoring. Pettus J; Edelman SV Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S234-42. PubMed ID: 26784128 [TBL] [Abstract][Full Text] [Related]
7. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial. Forlenza GP; Li Z; Buckingham BA; Pinsker JE; Cengiz E; Wadwa RP; Ekhlaspour L; Church MM; Weinzimer SA; Jost E; Marcal T; Andre C; Carria L; Swanson V; Lum JW; Kollman C; Woodall W; Beck RW Diabetes Care; 2018 Oct; 41(10):2155-2161. PubMed ID: 30089663 [TBL] [Abstract][Full Text] [Related]
8. Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna Trial. Agesen RM; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Jensen T; Parving HH; Thorsteinsson B; Tarnow L; Pedersen-Bjergaard U Diabetes Technol Ther; 2018 Mar; 20(3):247-256. PubMed ID: 29565719 [TBL] [Abstract][Full Text] [Related]
9. Study of MiniMed 640G Insulin Pump with SmartGuard in Prevention of Low Glucose Events in Adults with Type 1 Diabetes (SMILE): Design of a Hypoglycemia Prevention Trial with Continuous Glucose Monitoring Data as Outcomes. De Valk HW; Lablanche S; Bosi E; Choudhary P; Silva JD; Castaneda J; Vorrink L; De Portu S; Cohen O Diabetes Technol Ther; 2018 Nov; 20(11):758-766. PubMed ID: 30325656 [TBL] [Abstract][Full Text] [Related]
10. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study. Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial. Tumminia A; Crimi S; Sciacca L; Buscema M; Frittitta L; Squatrito S; Vigneri R; Tomaselli L Diabetes Metab Res Rev; 2015 Jan; 31(1):61-8. PubMed ID: 24816997 [TBL] [Abstract][Full Text] [Related]
12. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review. Golden SH; Sapir T J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955 [TBL] [Abstract][Full Text] [Related]
13. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes. Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E; Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304 [TBL] [Abstract][Full Text] [Related]
14. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial. Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D; JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453 [TBL] [Abstract][Full Text] [Related]
15. Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study. Reddy M; Jugnee N; Anantharaja S; Oliver N Diabetes Technol Ther; 2018 Nov; 20(11):751-757. PubMed ID: 30265562 [TBL] [Abstract][Full Text] [Related]
16. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes. Rodbard D Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879 [TBL] [Abstract][Full Text] [Related]
17. STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects. Davis SN; Horton ES; Battelino T; Rubin RR; Schulman KA; Tamborlane WV Diabetes Technol Ther; 2010 Apr; 12(4):249-55. PubMed ID: 20210562 [TBL] [Abstract][Full Text] [Related]
18. Sensitivity of the Predictive Hypoglycemia Minimizer System to the Algorithm Aggressiveness Factor. Finan DA; Dassau E; Breton MD; Patek SD; McCann TW; Kovatchev BP; Doyle FJ; Levy BL; Venugopalan R J Diabetes Sci Technol; 2015 Jun; 10(1):104-10. PubMed ID: 26134834 [TBL] [Abstract][Full Text] [Related]
19. Design and Methods of a Randomized Trial of Continuous Glucose Monitoring in Persons With Type 1 Diabetes With Impaired Glycemic Control Treated With Multiple Daily Insulin Injections (GOLD Study). Lind M; Polonsky W; Hirsch IB; Heise T; Bolinder J; Dahlqvist S; Pehrsson NG; Moström P J Diabetes Sci Technol; 2016 May; 10(3):754-61. PubMed ID: 27081191 [TBL] [Abstract][Full Text] [Related]
20. Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study. Šoupal J; Petruželková L; Flekač M; Pelcl T; Matoulek M; Daňková M; Škrha J; Svačina Š; Prázný M Diabetes Technol Ther; 2016 Sep; 18(9):532-8. PubMed ID: 27482825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]